ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2386

Patients’ Interpretations of Rheumatoid Arthritis Model Disease States in a Safety-Net Rheumatology Clinic

Carol Bledsoe1, Lisa A. Davis2, Vivian Tran3, Angela Keniston4, Liron Caplan5, Itziar Quinzanos6 and Joel M. Hirsh3, 1The Brody School of Medicine - East Carolina University, Greenville, NC, 2Denver VAMC and Univ of Colorado School of Medicine, Aurora, CO, 3Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO, 4Department of Medicine, Denver Health and Hospital Authority, Denver, CO, 5Div of Rheumatology, Denver VA and Univ of Colorado School of Medicine, Aurora, CO, 6Department of Medicine, Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Health Assessment Questionnaire, health literacy and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patient assessment of disease activity (PtGA) measured by visual analog scale (VAS) is often a barrier to patients achieving remission in rheumatoid arthritis (RA). The Boolean and Simplified Disease Activity Index (SDAI) criteria for remission mandate a PtGA of ≤10mm and ≤33mm, respectively. For this reason, it is critical to understand the patient perspective on model disease states, including remission. The objective of our study was to determine how a diverse cohort of RA patients interprets case scenarios of disease states, and to identify variables that were associated with rating the remission model disease state at ≤10mm and ≤33mm.

Methods: We enrolled English- and Spanish-speaking patients at our clinic who met American College of Rheumatology 2010 criteria for RA. We asked subjects to rate their health on a VAS if their arthritis were like that described in each of four case scenarios ranging from remission to severe RA disease activity. These scenarios included the domains: engagement in activities of daily living; personal care; anxiety related to the course of disease; leisure activity; pain; and side effects of treatment. Responses were classified according to Figure 1.  We performed multivariate logistic regression to identify predictors of: 1) scorable responses with the remission disease state rated lower than the severe disease state (category 4 [Cat 4]); 2) rating the remission model disease state ≤10mm; or ≤33mm.  

Results: We enrolled 300 subjects.  Only 128 subjects were grouped into Cat 4, indicating understanding of the scenarios.  By multivariate regression, higher health literacy (HL) (OR 1.20) and increasing education (OR 2.02) were associated with being grouped in Cat 4. The mean score for the remission scenario for Cat 4 was 17 mm. Of the Cat 4 subjects, 70% and 79% assigned the remission model scenario a score that would satisfy the Boolean and SDAI remission criteria, respectively. No socio-demographic variable predicted responses ≤10mm. Increasing income (OR 5.37) and decreasing pain scores (OR 0.79) predicted classification of the remission model scenario at a level of ≤33mm (Table 1).

Conclusion: Limited HL and education are associated with responses to the remission scenario that are inconsistent with understanding the VAS line or question content. Approximately 30% of the patients in Cat 4 rated the remission model disease state at a level that would preclude them from being judged in remission by the Boolean criteria. These results expand what is known about patient perspectives of remission and the challenges of meeting remission criteria in clinics caring for diverse and disadvantaged populations.

Figure 1: Responses to rheumatoid arthritis case scenarios of remission and severe rheumatoid arthritis disease activity, grouped into categories according to completion, scorability, and appropriateness of responses

 

 

 

Cat 1

 

 

 

Cat 2

No response
n=31

Unscorable responses such as writing along VAS line, circling anchor, etc.
n=45

 

 

 

Cat 3

 

 

 

Cat 4

Scorable responses, but remission scenario not rated lower than severe scenario
n=95

Scorable responses and remission scenario rated lower than severe scenario
n=128

Cat: category; RA: Rheumatoid arthritis

 

Table 1: Predictors of patient rating the clinical scenario describing remission rheumatoid arthritis with a patient global score ≤ 33mm (remission according to the Simplified Disease Activity Index, SDAI)

Univariate

Multivariate

Variable

OR

95% CI

p-value

OR

95% CI

p-value

Age, years

1.02

0.99

1.05

0.204

 

 

 

 

Sex (male)

0.50

0.18

1.38

0.181

0.31

0.08

1.18

0.085

Education Level

 

 

 

Some High School

REF

 

 

 

High School Degree or GED

2.21

0.68

7.24

0.190

2.06

0.45

9.38

0.349

 

Trade School

0.95

0.19

4.68

0.947

1.61

0.20

13.16

0.657

 

Some College

3.32

0.89

12.34

0.074

2.73

0.53

14.05

0.230

 

College Degree or above

1.80

0.51

6.38

0.362

0.66

0.12

3.48

0.620

Income >= $15,000/ year*

3.83

1.23

11.92

0.020

5.37

1.33

21.63

0.018

S-TOFHLA total score, (0-10)

1.12

0.91

1.37

0.284

 

Spanish language**

0.45

0.17

1.20

0.109

0.31

0.08

1.18

0.085

Confidence in Filling out medical forms

 

 

 

Not at all

REF

 

 

 

A little bit

4.00

0.12

136.96

0.442

 

 

Somewhat

1.90

0.11

33.70

0.662

 

 

Quite a bit

3.75

0.19

74.06

0.385

 

 

Extremely

5.64

0.33

96.96

0.234

 

MDHAQ score (0-3)

0.37

0.18

0.75

0.006

0.52

0.19

1.43

0.206

Fatigue Score (0-10)

0.93

0.80

1.07

0.301

 

Pain Score (0-10)

0.78

0.66

0.93

0.005

0.79

0.62

1.00

0.047

OR: odds ratio; S-TOFHLA: short test of functional health literacy in adults; MDHAQ: multi-dimensional health assessment questionnaire; GED = General Educational Development; * comparator is <$15,000 per year; ** comparator is English

 


Disclosure:

C. Bledsoe,
None;

L. A. Davis,
None;

V. Tran,
None;

A. Keniston,
None;

L. Caplan,
None;

I. Quinzanos,
None;

J. M. Hirsh,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-interpretations-of-rheumatoid-arthritis-model-disease-states-in-a-safety-net-rheumatology-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology